Dyax Corp, BioCryst Pharma Lead Tuesday's After-Hours Movers
March 31, 2015 at 19:40 PM EDT
Dyax Corp. (NASDAQ: DYAX) jumped nearly 49 percent to $24.90 a share in late trading Tuesday after the company said a Phase Ib trial ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|